On 28 September 2026, INNOVENT BIO (01801.HK) said Jaypirca won China's NMPA approval as a monotherapy for adult CLL/SLL patients across all lines of therapy.
On 28 Sept 2026, MINTH GROUP (00425.HK) posted H1 turnover of RMB13.41bn, up 9.1%, and attributable profit of RMB1.43bn, up 12.3%; no interim dividend.
On 27 Sept 2026, RAFFLESINTERIOR (01376.HK) said Mazars resigned as auditor citing unresolved audit issues; its shares remain suspended since 1 April 2026.
On 28 Sept 2026, CHINA VANKE (02202.HK) unit gave RMB200m mortgage to extend a loan; outstanding guarantees stood at RMB93.636bn, 80.10% of NAV.
On 28 Sept 2026, ESWIN COMPUTING (01256.HK) launched a global offering of 1.57bn H shares at up to HK$1.59, with listing expected on 9 October 2026.
On 27 Sept 2026, TESSON HOLDINGS (01201.HK) agreed to buy an EV-charging target for RMB98.4m paid partly in shares; a major transaction pending EGM approval.
Xinyi Energy (03868.HK) and Xinyi Solar (00968.HK) said the fund manager filed a PRC listing application on 21 September, accepted by SZSE on 24 September.
SHEIN-W (00625.HK) said its stabilisation period ended on 26 September and the over-allotment option lapsed unused, with no Class B Shares issued under it.
Hansoh (03692.HK) said the EU revoked the marketing authorisation for Aumolertinib (Aumseqa®) on 25 September over a procedural issue; a resubmission is planned.
Mech-Mind (09615.HK) said its stabilisation period ended on 26 September and the over-allotment option lapsed unused, with no H shares issued under it.
September 25, 2026, EAST NOVA HLDGS(03626.HK) released its Annual Report for the period ended June 30, 2026, Total Revenue stood at HKD 98.77 million, increased by 3.8% YoY
On 25 Sept 2026, TA YANG GROUP (01991.HK) further delayed to 9 Oct the circular for its proposed capital reorganisation and rights issue; timetable in review.
On 25 Sept 2026, ALCO HOLDINGS (00328.HK) said its RMB2m deal for an 11% JV stake was terminated; it later sold its whole JV interest for HKD5,000.
On 25 Sept 2026, LVJI TECH (01745.HK) further delayed to 16 Oct the circular for its very substantial disposal of debt claims, the second postponement.
On 25 Sept 2026, YUANHENG GAS (00332.HK) completed the placing of 65.45m new shares to at least six placees under the general mandate.
On 25 Sept 2026, NT PHARMA (01011.HK) said an arbitration award orders it and jointly liable parties to pay ~RMB75m; it has moved to set aside the award.
